AB-PINACA是一種有機化合物,化學式為C18H26N4O2。它最初由輝瑞公司於2009年作為鎮痛藥開發,[1][2]並在2012年於日本首次被鑑定為合成大麻素。[3]
Quick Facts 法律規範狀態, 法律規範 ...
AB-PINACA![Thumb](//upload.wikimedia.org/wikipedia/commons/thumb/6/67/AB-PINACA_structure-rev1.png/220px-AB-PINACA_structure-rev1.png) |
|
法律規範 |
|
---|
|
N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide
|
CAS號 | 1445752-09-9 Y |
---|
PubChem CID | |
---|
ChemSpider | |
---|
UNII | |
---|
CompTox Dashboard (EPA) | |
---|
|
化學式 | C18H26N4O2 |
---|
摩爾質量 | 330.43 g·mol−1 |
---|
3D模型(JSmol) | |
---|
CCCCCn1c2ccccc2c(n1)C(=O)N[C@@H](C(C)C)C(=O)N
|
InChI=1S/C18H26N4O2/c1-4-5-8-11-22-14-10-7-6-9-13(14)16(21-22)18(24)20-15(12(2)3)17(19)23/h6-7,9-10,12,15H,4-5,8,11H2,1-3H3,(H2,19,23)(H,20,24)/t15-/m0/s1 Key:GIMHPAQOAAZSHS-HNNXBMFYSA-N
|
Close
它是潛在的CB1受體(Ki = 2.87 nM,EC50 = 1.2 nM)和CB2受體(Ki = 0.88 nM,EC50 = 2.5 nM)的激動劑。[4][5]
這種合成大麻素有不少相關死亡和住院病例報告。[6]
- 5F-AB-PINACA
- 5F-ADB
- 5F-AMB
- 5F-APINACA
- 5F-CUMYL-PINACA
- AB-CHFUPYCA
- AB-FUBINACA
- AB-PICA
- ADB-CHMINACA
- ADB-FUBINACA
- ADB-PINACA
- ADBICA
- APICA
- APINACA
- MDMB-CHMICA
- PX-3
AB-PINACA. Cayman Chemical. [25 June 2015]. (原始內容存檔於2015-06-26).
Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicology. 2012, 31: 93–100. S2CID 25242453. doi:10.1007/s11419-012-0171-4.
Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chemical Neuroscience. September 2015, 6 (9): 1546–59. PMID 26134475. doi:10.1021/acschemneuro.5b00112.
Trecki J, Gerona RR, Schwartz MD. Synthetic Cannabinoid-Related Illnesses and Deaths. The New England Journal of Medicine. July 2015, 373 (2): 103–7. PMID 26154784. doi:10.1056/NEJMp1505328.